Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Olorinab
2. 1268881-20-4
3. Apd371
4. Apd-371
5. Olorinab [usan]
6. Apd 371 - Bio-x
7. 581f7dfa9b
8. Apd 371
9. (1as,5as)-2-(4-oxy-pyrazin-2-yl)-1a,2,5,5a-tetrahydro-1h-2,3-diaza-cyclopropa(a)pentalene-4-carboxylic Acid ((s)-1-hydroxymethyl-2,2-dimethyl-propyl)-amide
10. (2s,4s)-n-[(2s)-1-hydroxy-3,3-dimethylbutan-2-yl]-9-(4-oxidopyrazin-4-ium-2-yl)-8,9-diazatricyclo[4.3.0.02,4]nona-1(6),7-diene-7-carboxamide
11. (4as,5as)-n-((2s)-1-hydroxy-3,3-dimethylbutan-2-yl)-1-(4-oxidopyrazin-2-yl)-4,4a,5,5a-tetrahydro-1h-cyclopropa(4,5)cyclopenta(1,2-c)pyrazole-3-carboxamide
12. Olorinab [inn]
13. Unii-581f7dfa9b
14. Chembl4175981
15. Schembl11995430
16. Gtpl10058
17. Bdbm50285941
18. Compound 6 [pmid: 29259753]
19. Db14998
20. Ba165146
21. E88367
22. 3-((4as,5as)-3-(((s)-1-hydroxy-3,3-dimethylbutan-2-yl)carbamoyl)-4,4a,5,5a-tetrahydro-1h-cyclopropa[4,5]cyclopenta[1,2-c]pyrazol-1-yl)pyrazine 1-oxide
| Molecular Weight | 357.4 g/mol |
|---|---|
| Molecular Formula | C18H23N5O3 |
| XLogP3 | 0.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 5 |
| Exact Mass | 357.18008961 g/mol |
| Monoisotopic Mass | 357.18008961 g/mol |
| Topological Polar Surface Area | 106 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 553 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
96
PharmaCompass offers a list of Olorinab API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Olorinab manufacturer or Olorinab supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Olorinab manufacturer or Olorinab supplier.
PharmaCompass also assists you with knowing the Olorinab API Price utilized in the formulation of products. Olorinab API Price is not always fixed or binding as the Olorinab Price is obtained through a variety of data sources. The Olorinab Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Olorinab manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Olorinab, including repackagers and relabelers. The FDA regulates Olorinab manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Olorinab API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Olorinab supplier is an individual or a company that provides Olorinab active pharmaceutical ingredient (API) or Olorinab finished formulations upon request. The Olorinab suppliers may include Olorinab API manufacturers, exporters, distributors and traders.
Olorinab Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Olorinab GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Olorinab GMP manufacturer or Olorinab GMP API supplier for your needs.
A Olorinab CoA (Certificate of Analysis) is a formal document that attests to Olorinab's compliance with Olorinab specifications and serves as a tool for batch-level quality control.
Olorinab CoA mostly includes findings from lab analyses of a specific batch. For each Olorinab CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Olorinab may be tested according to a variety of international standards, such as European Pharmacopoeia (Olorinab EP), Olorinab JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Olorinab USP).
